anti-HAVcr-1 antibodies (NIH OTT)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-HAVcr-1 antibodies (NIH OTT)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT-cell immunoglobulin mucin receptor 1 inhibitorsT-cell immunoglobulin mucin receptor 1 modulators
TargetsT-cell immunoglobulin mucin receptor 1
Therapy Area/IndicationsKidney Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsKidney Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A